Maria E. Balasis
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 19
- Acute Myeloid Leukemia Research 17
- Chronic Myeloid Leukemia Treatments 9
-
- Histone Deacetylase Inhibitors Research 6
- Ubiquitin and proteasome pathways 4
- Heat shock proteins research 2
- Cell death mechanisms and regulation 2
- Co-authors
- Warren Fiskus (10 shared papers)Michael Pranpat (10 shared papers)Kapil N. Bhalla (10 shared papers)Purva Bali (9 shared papers)Kathy Rocha (9 shared papers)Sandhya Kumaraswamy (8 shared papers)Sandhya Boyapalle (7 shared papers)Peter Atadja (4 shared papers)
- Journals
- Blood (17 papers)Clinical Cancer Research (4 papers)Marine Drugs (2 papers)Leukemia (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Maria E. Balasis
34 papers receiving 1.8k citations
Maria E. Balasis's Hit Papers
Peers
Comparison fields: 5 of 80
- Hematology 565
- Genetics 308
- Molecular Biology 1.3k
- Oncology 282
- Cancer Research 110
Countries citing papers authored by Maria E. Balasis
This map shows the geographic impact of Maria E. Balasis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria E. Balasis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria E. Balasis more than expected).
Fields of papers citing papers by Maria E. Balasis
This network shows the impact of papers produced by Maria E. Balasis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria E. Balasis. The network helps show where Maria E. Balasis may publish in the future.
Co-authors
The 25 scholars most cited alongside Maria E. Balasis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90 Hit paper breakdown → | 2005 | 666 |
| 2 | 2016 | 213 | |
| 3 | 2005 | 187 | |
| 4 | 2005 | 163 | |
| 5 | 2006 | 125 | |
| 6 | 2006 | 102 | |
| 7 | 2006 | 84 | |
| 8 | 2016 | 67 | |
| 9 | 2011 | 56 | |
| 10 | 2020 | 34 | |
| 11 | 2018 | 29 | |
| 12 | 2014 | 24 | |
| 13 | 2014 | 18 | |
| 14 | 2017 | 14 | |
| 15 | 2014 | 13 | |
| 16 | 2019 | 12 | |
| 17 | 2022 | 10 | |
| 18 | 2023 | 7 | |
| 19 | 2013 | 7 | |
| 20 | 2015 | 5 |
About Maria E. Balasis
Maria E. Balasis is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Organic Chemistry, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Histone Deacetylase Inhibitors Research (6 papers), Ubiquitin and proteasome pathways (4 papers), Heat shock proteins research (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Hematology (565 citations), Genetics (308 citations), Molecular Biology (1.3k citations), Oncology (282 citations) and Cancer Research (110 citations). Maria E. Balasis has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Warren Fiskus, Michael Pranpat, Kapil N. Bhalla, Purva Bali, Kathy Rocha, Sandhya Kumaraswamy, Sandhya Boyapalle, Peter Atadja, Fei Guo and Edward Seto. Their work appears in journals such as Blood, Clinical Cancer Research, Marine Drugs, Leukemia and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.